ShermanGraham8 at 20:53, 13 October 2025

2025-10-13T20:53:31Z

New page

{{Short description|Indian pharmaceutical company}}

{{Use dmy dates|date=August 2018}}
{{Use Indian English|date=August 2018}}
{{Infobox company
| name = Cadila Pharmaceuticals Limited
| logo = Cadila Pharmaceuticals.svg
| logo_size = 220px
| logo_alt = Cadila_Pharmaceuticals_Logo
| image = Cadilla Pharmaceuticals HQ.jpg
| image_size = 250px
| image_caption = Headquarters in [[Ahmedabad]]
| type = [[Private company|Private]]
| foundation = 1951
| founder = [[Indravadan Modi]]
| location_city = [[Ahmedabad]], [[Gujarat]]
| num_employees = 8,000
| subsid = IRM Ltd
| location_country = India
| key_people = Rajiv Modi <br />(Chairman and Managing Director)
| industry = [[Pharmaceutical industry|Pharmaceuticals]]
| products = [[Active ingredient|API]]s, [[generic drug]]s
| services = {{ubl|[[Contract research organization|Contract research]]|[[Contract manufacturing]]}}
| revenue = {{up}} {{INRConvert|3675|c}} (FY23)<ref name="FY23"/>
| net_income = {{down}} {{INRConvert|-10|c}} (FY23)<ref name="FY23">{{cite web |title=Cadila Pharmaceuticals Limited |url=https://www.crediwatch.com/party/55675e4e6d6f6f263ac91704/financials |publisher=Crediwatch |access-date=18 December 2023|url-access=registration}}</ref>
| homepage = {{URL|http://www.cadilapharma.com/}}
}}

'''Cadila Pharmaceuticals''' is an Indian [[multinational corporation|multinational]] pharmaceutical company based in [[Ahmedabad]]. The company's operations focus on manufacturing products ranging from [[Active ingredient|active pharmaceutical intermediates]], [[Pharmaceutical formulation|finished formulations]], food supplements, [[biotechnology]] products and pharmaceutical machinery.<ref name="Bureau 2023 v619">{{cite web |last= |first= |date=2023-03-22 |title=Cadila Pharma to expand and upgrade its existing facilities in Gujarat |url=https://www.thehindubusinessline.com/companies/cadila-pharma-to-expand-and-upgrade-its-existing-facilities-in-gujarat/article66649134.ece |access-date=2023-09-11 |website=BusinessLine}}</ref>

== History ==
In 1951 Indravadan A Modi had quit his job as a chemist in a Mumbai firm to start Cadila Laboratories with childhood friend Ramanbhai Patel. The company started in a rented bungalow with a capital of Rs 25,000 and achieved a turnover of around Rs 1.25 lakh in its first year of operation.<ref name="auto">{{cite web|url=https://www.business-standard.com/article/companies/carrying-the-legacy-forward-rajiv-modi-114012801184_1.html|title=Carrying the legacy forward: Rajiv Modi|first=Sohini|last=Das|date=28 January 2014|publisher=|via=Business Standard}}</ref>

The Modi and Patel families decided to split the business in 1995, and two entities were formed: '''Cadila Pharmaceuticals Ltd''' (owned and controlled by Indravadan Modi and his son Rajiv Modi) and [[Cadila Healthcare]] (owned by Ramanbhai Patel and his son Pankaj Patel family).<ref name="auto"/>

In 2019, Cadila Pharmaceuticals formed a partnership with Norwegian start-up, Serca Pharmaceuticals to develop new treatment for heart patients.<ref>{{Cite web|url=https://www.thehindubusinessline.com/companies/cadila-pharma-inks-pact-with-norwegian-start-up-to-develop-new-treatment-for-heart-patients/article25960391.ece|title=Cadila Pharma inks pact with Norwegian start-up to develop new treatment for heart patients|website=@businessline|date=10 January 2019 |language=en|access-date=2019-01-11}}</ref>

In November 2023, the company opened an active pharmaceutical ingredient (API) plant in [[Dahej]], in Gujarat's [[Bharuch district]]. The facility was built with an investment of ₹200 crore, and is equipped with distributed control system (DCS) automation technology. <ref>{{Cite web |title=Business today |date=27 November 2023 |url=https://www.businesstoday.in/industry/pharma/story/cadila-pharmaceuticals-inaugurates-rs-200-crore-api-plant-in-dahej-aims-to-expand-to-new-markets-407301-2023-11-27}}</ref>

== Operations ==
Cadila Pharmaceuticals has its formulation manufacturing facilities at Dholka, Gujarat (India); Samba, Jammu (India) and at Addis Ababa (Ethiopia) and 2 API manufacturing facilities are located at Ankleshwar, Gujarat. The manufacturing facility at Dholka and the API unit at Ankleshwar in Gujarat are USFDA-certified; the overseas manufacturing facility at Ethiopia is the WHO - cGMP compliant facility.<ref>[http://pharma.financialexpress.com/sections/management/1698-caring-cadila Financial Express 28 January 2013]</ref>

== Controversies ==

=== Company ===
In 2014, a cautionary notice appeared on the US [[Food and Drug Administration]] (FDA) website, highlighting substantial manufacturing practice discrepancies discovered by inspectors in March at Cadila Pharmaceuticals' [[Ankleshwar]] facility in Gujarat.<ref>{{Cite news |last1=Mishra |first1=Digbijay |last2=Das |first2=Sohini |date=13 November 2014 |title=US FDA scolds Cadila Pharma over manufacturing practice in Gujrat plant |url=https://www.business-standard.com/article/companies/us-fda-scolds-cadila-pharma-over-manufacturing-practice-in-gujrat-plant-114111201228_1.html |access-date=6 January 2024}}</ref> This incident marked one among several Indian pharmaceutical companies receiving regulatory warnings from the FDA, indicating increased scrutiny on generic drugmakers.<ref>{{Cite news |date=12 November 2014 |title=FDA warns Cadila Pharma over drug production processes |url=https://www.reuters.com/article/cadila-pharmaceuticals-india-usa/fda-warns-cadila-pharma-over-drug-production-processes-idINKCN0IW0EH20141112/ |access-date=6 January 2023 |work=[[Reuters]]}}</ref> A similar kind of notices were again issued in 2016<ref>{{Cite news |last=RAJAGOPAL |first=DIVYA |date=2016-01-01 |title=Cadila gets US FDA warning for violating standards at Moraiya and Ahmedabad plants |url=https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cadila-gets-us-fda-warning-for-violating-standards-at-moraiya-and-ahmedabad-plants/articleshow/50390452.cms |access-date=2024-01-06 |work=The Economic Times |issn=0013-0389}}</ref> and 2019.<ref>{{Cite web |last=Research |first=Center for Drug Evaluation and |date=2022-11-28 |title=Cadila Healthcare Limited - 584856 - 10/29/2019 |url=https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cadila-healthcare-limited-584856-10292019 |access-date=2024-01-06 |website=Center for Drug Evaluation and Research |language=en}}{{dead link|date=May 2025|bot=medic}}{{cbignore|bot=medic}}</ref>

=== Management ===
In 2018, the chairman of the company, Rajiv Modi, went through a widely publicized and contentious divorce with his wife, Monica, who comes from a prominent Mumbai-based business family of Garware. At that time, Modi transferred {{INRConvert|200|c|lk=off|year=2023}} to Monica, who relinquished her rights, while custody of their son was awarded to Modi.<ref>{{Cite news |date=2018-10-31 |title=Gujarat: Cadila Pharma owner pays wife Rs 200 crore |url=https://timesofindia.indiatimes.com/city/ahmedabad/cadila-pharma-owner-pays-wife-rs-200-crore/articleshow/66436382.cms |access-date=2024-01-06 |work=The Times of India |issn=0971-8257}}</ref><ref>{{Cite web |title=Cadila Pharmaceuticals boss Rajiv Modi swallows a Rs 200-cr divorce pill |url=https://www.dnaindia.com/business/report-cadila-pharmaceuticals-boss-rajiv-modi-swallows-a-rs-200-cr-divorce-pill-2681136 |access-date=2024-01-06 |website=DNA India |language=en}}</ref>

== References ==
{{reflist}}

==External links==
* {{Official website|http://cadilapharma.com/}}

[[Category:Pharmaceutical industry in Gujarat]]
[[Category:Pharmaceutical industry in India| ]]
[[Category:Pharmaceutical companies of Gujarat]]
[[Category:Companies based in Ahmedabad]]
[[Category:Pharmaceutical companies established in 1951]]
[[Category:Pharmaceutical companies of India]]
[[Category:Indian brands]]
[[Category:1951 establishments in Bombay State]]

Cadila Pharmaceuticals - Revision history

ShermanGraham8 at 20:53, 13 October 2025